West Kazakhstan Medical Journal
ISSN: 2707-6180 (Print) 2707-6199 (Online)
Pioneering research advancing the frontiers of medical knowledge and healthcare practices.
Proliferation and Apoptosis in H. Pylori-associated Chronic Gastritis with Epithelial Metaplasia
Published date: Mar 25 2025
Journal Title: West Kazakhstan Medical Journal
Issue title: West Kazakhstan Medical Journal: Volume 67 Issue 1
Pages: 123 - 131
Authors:
Abstract:
Helicobacter pylori - causes pathologies such as gastritis, peptic ulcer disease, adenocarcinoma. Pseudopyloric mucosal metaplasia in the incisura region is significantly correlated with the development of precancerous changes - atrophy and intestinal metaplasia. Pseudopyloric metaplasia of the gastric mucosa develops as a result of persistence of H. pylori infection. Immunohistochemical and histological study of gastric mucosa biopsy specimens from patients with dyspeptic complaints was performed. Chronic non-atrophic gastritis was histologically detected in 21 patients. Of these, 17 (80.95%) were H. pylori-positive. Out of 55 patients with chronic atrophic gastritis, 38 (69.1%) were H. pylori-positive. Ki-67 IM was significantly increased during the development of atrophic gastritis: in the antral region to 50.6±8.3 (P<0.05), in atrophy and pseudopyloric metaplasia in the incisura region to an average of 47.3±8.2 (P<0.05) and in the gastric body region to an average of 46.9±7.4 (P<0.05). In chronic atrophic gastritis, p53 expression was detected in the antral region in 22 (40.0%) patients, and in atrophy and pseudopyloric metaplasia in the incisura region in 18 (50.0%) and in the body in 4 (57.1%). All patients were H. pylori-positive. Intestinal metaplasia was found in 36 (65.5%) patients in the antral region, 34 (61.8%) patients in the incisura region and 24 (43.6%) patients in the body of the stomach This study showed that in chronic H. pylori-associated atrophic gastritis there is an acceleration of cell proliferation and impaired apoptosis, especially in areas of atrophy, as well as pseudopyloric and intestinal epithelial metaplasia, leading to an increased risk of gastric cancer.
Keywords: H. pylori, atrophy, metaplasia, proliferation, stomach cancer
References:
[1] Nasri B, Inokuchi M, Ishikawa T, Uetake H, Takagi Y, Otsuki S, et al. High expression of EphA3 (erythropoietinproducing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival. BMC Clin Pathol. 2017;17:8.
[2] FT B, F C, RH H, ND T . WHO Classification of Tumours of the Digestive System [Internet]. [cited 2025 Feb 12]. Available from: https:// publications.iarc.fr /Book-And-Report-Series/Who-Classification-Of- Tumours/ WHOClassification-Of- Tumours-Of- The-Digestive-System-2010
[3] Bray F , Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
[4] Thrift AP, El‑Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 Mar;18(3):534–42.
[5] Cancer Today [Internet]. [cited 2025 Feb 12]. Available from: https://gco.iarc.who.int/today/
[6] Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer . 2017 Mar;20(Suppl 1):3–7.
[7] Graham DY, Zou WY. Guilt by association: intestinal metaplasia does not progress to gastric cancer . Curr Opin Gastroenterol. 2018 Nov;34(6):458–64.
[8] VillanoV , Di Stadio CS, Federico A, AltieriF , Miselli G, De Palma M, et al. Gastrokine 1 mRNA in human sera is not informative biomarker for gastric cancer . J Negat Results Biomed. 2016 Jul 25;15(1):14.
[9] Pernot S, VoronT , Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015 Oct 28;21(40):11428–38.
[10] Asombang AW, KellPy . Gastric cancer in Africa: what do we know about incidence and risk factors? Trans R Soc Trop Med Hyg. 2012 Feb;106(2):69–74.
[11] Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, et al. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol. 2000 Jan;95(1):114–21.
[12] MehrboPd , Ande SR, Alizadeh J, Rahimizadeh S, Shariati A, Malek H, et al. The roles of apoptosis, autophagy and unfolded protein response in arbovirus, influenza virus, and HIV infections. Virulence. 2019 Apr 30;10(1):376–413.
[13] Cancer (IARC) TIA for R on. Global Cancer Observatory [Internet]. [cited 2025 Feb 12]. Available from: https://gco.iarc.fr/
[14] Jacob T, Hingorani A, Ascher E. p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia. Vasc Endovascular Surg. 2012 Jan;46(1):45–53.
[15] Starzyńska T. [Protein p53 in gastric carcinoma: clinical use of cancer research on neoplasms]. Pol Merkur Lekarski. 1999 Feb;6(32):61–4.
[16] Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol. 1997 Dec;151(6):1695–703.
[17] Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, et al. Analysis of p53 gene mutations in Helicobacter pylori-associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol. 1999 May;34(5):474–7.
[18] Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 2001 Jan;96(1):16–26.